These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32008389)

  • 1. All Suicidal Ideation Is Not Created Equal: Two Cases of Suicide Attempts During Maintenance Ketamine Treatment.
    Cusin C; Sakurai H; Bentley K; Pedrelli P; Foster S; Fava M; Mischoulon D
    Am J Psychiatry; 2020 Feb; 177(2):173-174. PubMed ID: 32008389
    [No Abstract]   [Full Text] [Related]  

  • 2. Ketamine for chronic depression: two cautionary tales.
    Talbot J; Phillips JL; Blier P
    J Psychiatry Neurosci; 2019 Nov; 44(6):384-385. PubMed ID: 31573153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ketamine treatment on suicidal ideation: a qualitative study of patients' accounts following treatment for depression in a UK ketamine clinic.
    Lascelles K; Marzano L; Brand F; Trueman H; McShane R; Hawton K
    BMJ Open; 2019 Aug; 9(8):e029108. PubMed ID: 31420388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subanesthetic ketamine infusions for suicide ideation in patients with bipolar and unipolar treatment refractory depression.
    Kang MJY; Kulcar E; Chandrasena R; Anjum MR; Fairbairn J; Hawken ER; Vazquez GH
    Psychiatry Res; 2021 Feb; 296():113645. PubMed ID: 33360430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report.
    Bartova L; Weidenauer A; Dold M; Naderi-Heiden A; Kasper S; Willeit M; Praschak-Rieder N
    J ECT; 2017 Sep; 33(3):e31-e32. PubMed ID: 28520578
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of action of ketamine.
    Stahl SM
    CNS Spectr; 2013 Aug; 18(4):171-4. PubMed ID: 23866089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Remote Monitoring of Intranasal Ketamine Self-Administration as Maintenance Therapy in Treatment-Resistant Depression (TRD): A Novel Strategy for Vulnerable and At-Risk Populations to COVID-19?".
    Longpré-Poirier C; Desbeaumes Jodoin V; Miron JP; Lespérance P
    Am J Geriatr Psychiatry; 2020 Aug; 28(8):892-893. PubMed ID: 32446640
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study.
    Ionescu DF; Swee MB; Pavone KJ; Taylor N; Akeju O; Baer L; Nyer M; Cassano P; Mischoulon D; Alpert JE; Brown EN; Nock MK; Fava M; Cusin C
    J Clin Psychiatry; 2016 Jun; 77(6):e719-25. PubMed ID: 27232360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Ketamine the Future Clozapine for Depression? A Case Series and Literature Review on Maintenance Ketamine in Treatment-resistant Depression With Suicidal Behavior.
    Chan LF; Eu CL; Soh SY; Maniam T; Shahidii Kadir Z; Chong BTW; Loo JL; Sharip S; Wong VCW; Loo TH; Ng YP; Kahn DA
    J Psychiatr Pract; 2018 Jul; 24(4):279-291. PubMed ID: 30427812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial.
    Murrough JW; Soleimani L; DeWilde KE; Collins KA; Lapidus KA; Iacoviello BM; Lener M; Kautz M; Kim J; Stern JB; Price RB; Perez AM; Brallier JW; Rodriguez GJ; Goodman WK; Iosifescu DV; Charney DS
    Psychol Med; 2015 Dec; 45(16):3571-80. PubMed ID: 26266877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promises and concerns regarding the use of ketamine and esketamine in the treatment of depression.
    Pérez-Esparza R; Kobayashi-Romero LF; García-Mendoza AM; Lamas-Aguilar RM; Fonseca-Perezamador A
    Acta Psychiatr Scand; 2019 Aug; 140(2):182-183. PubMed ID: 31251388
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.
    McIntyre RS; Rosenblat JD; Nemeroff CB; Sanacora G; Murrough JW; Berk M; Brietzke E; Dodd S; Gorwood P; Ho R; Iosifescu DV; Lopez Jaramillo C; Kasper S; Kratiuk K; Lee JG; Lee Y; Lui LMW; Mansur RB; Papakostas GI; Subramaniapillai M; Thase M; Vieta E; Young AH; Zarate CA; Stahl S
    Am J Psychiatry; 2021 May; 178(5):383-399. PubMed ID: 33726522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine Use for Suicidal Ideation in the General Hospital: Case Report and Short Review.
    Vulser H; Vulser C; Rieutord M; Passeron A; Lefebvre D; Baup E; Seigneurie AS; Thauvin I; Limosin F; Lemogne C
    J Psychiatr Pract; 2018 Jan; 24(1):56-59. PubMed ID: 29320385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.
    Ionescu DF; Bentley KH; Eikermann M; Taylor N; Akeju O; Swee MB; Pavone KJ; Petrie SR; Dording C; Mischoulon D; Alpert JE; Brown EN; Baer L; Nock MK; Fava M; Cusin C
    J Affect Disord; 2019 Jan; 243():516-524. PubMed ID: 30286416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials.
    Witt K; Potts J; Hubers A; Grunebaum MF; Murrough JW; Loo C; Cipriani A; Hawton K
    Aust N Z J Psychiatry; 2020 Jan; 54(1):29-45. PubMed ID: 31729893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Repeated Ketamine Infusion Over Facial Emotion Recognition in Treatment-Resistant Depression: A Preliminary Report.
    Shiroma PR; Albott CS; Johns B; Thuras P; Wels J; Lim KO
    J Neuropsychiatry Clin Neurosci; 2015; 27(4):362-4. PubMed ID: 25658683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suicidality in treatment resistant depression: perspective for ketamine use.
    Jakuszkowiak-Wojten K; Gałuszko-Węgielnik M; Wilkowska A; Słupski J; Włodarczyk A; Górska N; Szarmach J; Szałach ŁP; Wiglusz MS; Krysta K; Cubała WJ
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):258-260. PubMed ID: 31488737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral ketamine augmentation for chronic suicidality in treatment-resistant depression.
    De Gioannis A; De Leo D
    Aust N Z J Psychiatry; 2014 Jul; 48(7):686. PubMed ID: 24452289
    [No Abstract]   [Full Text] [Related]  

  • 19. Single-dose ketamine followed by daily D-Cycloserine in treatment-resistant bipolar depression.
    Kantrowitz JT; Halberstam B; Gangwisch J
    J Clin Psychiatry; 2015 Jun; 76(6):737-8. PubMed ID: 26132675
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterizing the course of suicidal ideation response to ketamine.
    Ballard ED; Yarrington JS; Farmer CA; Richards E; Machado-Vieira R; Kadriu B; Niciu MJ; Yuan P; Park L; Zarate CA
    J Affect Disord; 2018 Dec; 241():86-93. PubMed ID: 30099268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.